Every 8-K that ASCEND WELLNESS HOLDNGS A (AAWH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AAWH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAWH filings page.
Ascend Wellness Holdings, Inc. (AAWH) reported the results of a special meeting of stockholders held on August 28, 2026. Holders of Class A common stock approved an amendment to the Certificate of Incorporation authorizing a reverse stock split of Class A shares at a ratio between 1-for-10 and 1-for-50, to be implemented at the Board of Directors’ discretion before a national exchange listing or within one year of the meeting, whichever occurs first. Stockholders also approved the ability to adjourn the special meeting if needed to solicit additional proxies, although no adjournment was ultimately required. No other matters were considered or voted upon.
Ascend Wellness Holdings, Inc. reported Q2 2026 net revenue of $126.1 million, up from $116.9 million in Q1 2026, driven by an 11.5% sequential increase in retail revenue to $92.7 million as new and partner stores ramped. Wholesale revenue was $33.4 million, roughly flat sequentially amid pricing pressure, particularly in New Jersey.
Gross profit was $45.5 million (36.1% margin), while Adjusted Gross Profit reached $58.3 million, a 46.2% margin. Adjusted EBITDA rose to $29.1 million with a 23.1% margin, and net loss narrowed to $9.8 million from $29.5 million in Q1 2026 and $24.4 million a year earlier. The company generated $22.5 million of operating cash flow and $19.5 million of Free Cash Flow, ending the quarter with $67.0 million in cash and Net Debt of $251.8 million.
Ascend expanded its retail footprint to 55 locations (including partners), up from 48 in Q1 and 39 in August 2024, and reported ~5% combined market share growth across seven states with ~7% more retail transactions. It filed a definitive proxy for a reverse stock split to support a planned uplisting to a major U.S. exchange, submitted DEA registration applications under the Schedule III pathway, and resolved a work stoppage at its Barry, Illinois facility. For Q3 2026, it anticipates a 2–4% revenue increase and Adjusted EBITDA margin consistent with Q2.
Ascend Wellness Holdings, Inc. changed its corporate bylaws to make it easier to reach a quorum at shareholder meetings. Effective June 24, 2026, the required quorum was reduced from a majority of voting power to one third (1/3) of the company’s voting power issued and outstanding and entitled to vote. This lower threshold applies to stockholders present in person, by permitted remote communication, or by proxy, unless a higher requirement is set by law or the certificate of incorporation. The full text of the amended and restated bylaws is attached as an exhibit.
Ascend Wellness Holdings reported Q1 2026 results with net revenue of $116.9 million and a net loss of $29.5 million. Revenue declined 3.0% sequentially as both retail and wholesale sales softened due to seasonality, pricing pressure, competition, and weather-related store closures.
Gross profit was $44.9 million, while Adjusted Gross Margin improved to 46.1% on greater vertical integration and better retail margins. Adjusted EBITDA was $26.3 million with a 22.5% margin. Cash and cash equivalents were $60.9 million and Net Debt was $241.2 million as of March 31, 2026.
The company added five new dispensaries year-to-date to reach 51 locations and expects about 2–3% revenue growth in Q2 2026 with Adjusted EBITDA Margin in the low‑20% range. Management highlighted strong brand performance, growing loyalty program engagement, and potential future benefits from U.S. cannabis rescheduling and related tax changes.
Ascend Wellness Holdings, Inc. converted its entire dual-class, high-vote stock and simplified its capital structure. On May 4, 2026, all 65,000 issued and outstanding shares of Class B common stock, which carried 1,000 votes per share, automatically converted into an equal number of Class A common shares.
On May 5, 2026, the company filed a Certificate of Retirement to retire those Class B shares, reducing authorized common stock by 65,000 to 750,035,000 and authorized Class B shares to 35,000. At its 2026 annual meeting, stockholders elected six directors, overwhelmingly ratified WithumSmith+Brown, PC as auditor, and reapproved the stock incentive plan, with Proposal 3 receiving 98,316,897 votes for and 339,972 against.
Ascend Wellness Holdings reported Q4 2025 net revenue of $120.5 million and full-year 2025 revenue of $500.6 million, down from $561.6 million in 2024. The company posted a 2025 net loss of $118.2 million, wider than $85.0 million a year earlier, including a $17.0 million arbitration settlement expense in Q4.
Profitability metrics improved, with 2025 Adjusted EBITDA of $116.9 million and a 23.4% Adjusted EBITDA Margin, slightly above 2024. Cash and cash equivalents were $85.7 million as of December 31, 2025, with Net Debt of $215.8 million. The retail footprint reached 48 locations and a buyback retired about 15.8 million shares at an average $0.32 per share.
Ascend Wellness Holdings, Inc. resolved an arbitration dispute with Green Thumb Industries Inc. and TWD18, LLC stemming from a June 2018 side letter agreement. An arbitrator had issued a net award of approximately $19.7 million in favor of Green Thumb.
The parties then entered into a settlement agreement dated February 11, 2026, under which the matter was fully resolved for a negotiated payment of $17.0 million. Ascend Wellness has paid this amount, the award has been fully satisfied and extinguished, all arbitration claims have been resolved, and the company states it does not expect any material disruption to its ongoing operations.
Ascend Wellness Holdings released preliminary, unaudited results for Q4 and full year 2025, showing net revenue of approximately $120 million for Q4 and $500 million for the year. Q4 Adjusted EBITDA is projected at about $30 million, with a ~25% margin, and full-year Adjusted EBITDA at roughly $117 million, a ~23% margin.
The company reported cash and cash equivalents of about $86 million as of December 31, 2025 and no significant debt maturities until 2029. Management highlighted expansion to 47 retail stores and a broader branded product portfolio. An arbitration award was issued in favor of Green Thumb Industries related to a 2018 side letter; Ascend disagrees and is evaluating its options but states it can satisfy the award while maintaining planned operations and loan covenant compliance. A Q4 and full-year earnings call is scheduled for March 12, 2026 at 5:00 p.m. ET.
Ascend Wellness Holdings, Inc. disclosed an adverse arbitration outcome related to a 2018 side letter with Green Thumb Industries. The arbitrator found that both parties breached the agreement’s purchase obligations and awarded Green Thumb about $22 million in damages and Ascend about $2.3 million, resulting in a net award to Green Thumb of roughly $19.7 million. Ascend disagrees with the decision and is evaluating its options but does not currently expect the award to cause any material disruption to its ongoing operations.
Ascend Wellness Holdings (AAWH) furnished quarterly results. The company reported that it issued a press release announcing financial results for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to an 8-K.
The information was provided under Item 2.02 and is designated as “furnished,” not “filed,” which limits its use under the Exchange Act. The press release is dated November 10, 2025, and the 8-K was signed by Chief Financial Officer Roman Nemchenko.